LFST LifeStance Health Group, Inc. Insider Trading

Director Bessler sells 575,034 shares of LFST at $8.02 for $4.6M, retaining 1.10M shares near 52-week high.

Director Robert Bessler sold 575,034 shares at $8.02, generating $4,611,772.68 in proceeds, while the stock's current price of $7.89 sits -11.2% below its 52-week high of $8.89. The sale occurred against a backdrop of notable recent price strength — the stock gained +21.2% over the prior 30 days — placing the transaction near the upper end of LFST's trading range. Despite the sizable disposal, Bessler retains 1,103,729 shares post-transaction, indicating continued meaningful economic exposure to the company. Investors may watch whether this sale, executed close to the 52-week high amid a strong near-term rally, reflects a near-peak disposition, particularly given LFST's elevated P/E of 131.50 relative to its $14.2M net income on $403.5M in quarterly revenue.

Director Eric Shuey sells 243.4K LFST shares at $8.02; retains 867.6K shares post-transaction

Director Eric Shuey sold 243,362 shares valued at $1,951,763.24 on 2026-05-12 at $8.02, while retaining a substantial position of 867,562 shares. The sale occurred above the current price of $7.89 but near the upper end of the 52-week range ($3.74–$8.89), suggesting the director executed this transaction at a relatively elevated valuation point. The company's fundamentals show solid growth with annual revenue growth of +13.8% and a quarterly revenue of $403,476,000.00, though the P/E of 131.50 reflects significant valuation premium relative to the $14,243,000.00 net income. The timing coincides with the stock being +21.2% over 30 days and +12.2% over 90 days, positioning the sale within a period of positive momentum.

Darren M. Black sold 5.90M LFST shares at $8.02 (5/12/26) for $47.3M, retaining 23.31M shares; stock now at $7.89.

Director Darren M. Black executed a substantial $47.3M sale of 5,899,661 shares at $8.02 on 2026-05-12, reducing his position by 20% while still maintaining significant ownership of 23.31M shares. His prior three sales at LFST show poor timing: each post-sale period saw the stock rise (30d returns of -9.1%, +1.6%, and -10.2%; 90d returns of +15.6%, +26.2%, and +2.2%), with a 0% well-timed rate at the 90-day mark. The current price of $7.89 is below the $8.02 sale price and 11.2% below the 52-week high, though the stock has gained 21.2% over the past 30 days. Given the company's high P/E of 131.50, revenue growth of 13.8%, and his consistent pattern of selling into rallies that subsequently continue higher, this sale provides a signal worth monitoring but does not yet indicate a structural conviction shift by an insider with a demonstrated track record of sub-optimal exit timing.

TPG GP A, LLC sells 28.28M LFST shares ($226.8M) at $8.02; remains top holder with 111.74M shares post-sale

TPG GP A, LLC's substantial sale of 28,281,943 shares for $226,821,182.86 represents a meaningful but measured reduction by a 10% owner, leaving it as a dominant stakeholder with 111,744,614 shares remaining. Despite the large dollar volume, the sale occurred when stock was -11.2% from its 52-week high of $8.89, and the current price of $7.89 sits slightly below the $8.02 sale price—neither an obvious peak exit nor a distressed sale. The seller's track record shows limited success timing sales (22.22% well-timed rate on 13 prior sells), and LFST's fundamentals remain mixed: strong revenue growth at +13.8% annually but challenged valuation at P/E 131.50 with thin net income of $14.2M on $403.5M in revenue. The sale signals capital deployment activity by a major shareholder but does not necessarily reflect loss of confidence, given the retained 111.74M-share position.